Drug Profile
Hydrocodone controlled release - DURECT Corporation
Alternative Names: PTI 721Latest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator DURECT Corporation
- Developer Pain Therapeutics
- Class Antitussives; Morphinans; Opioid analgesics; Opioid peptides; Small molecules
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain